Memantine for Prevention of Cognitive Late Effects in Pediatric Patients Receiving Cranial Radiation Therapy for Localized Brain Tumors: A Pilot Study
Phase of Trial: Phase II
Latest Information Update: 20 Apr 2018
Price : $35 *
At a glance
- Drugs Memantine (Primary)
- Indications Cognition disorders
- Focus Therapeutic Use
- 27 Sep 2017 Planned End Date changed from 31 Jan 2021 to 1 Jan 2021.
- 27 Sep 2017 Planned primary completion date changed from 31 Jan 2021 to 1 Jan 2021.
- 04 Aug 2017 Status changed from not yet recruiting to recruiting.